Imperative Care presents Symphony Thrombectomy System pivotal trial in acute PE
Read the original on Endovascular Today (opens in a new tab)
Media contacts
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
In the media
Medical Product Outsourcing
Promising results reported from Imperative Care’s Symphony Thrombectomy System study
Diagnostic & International Cardiology
Imperative Care announces trial results of thrombectomy system in patients with acute pulmonary embolism
Mass Device